Why Is Lee Cooperman Bullish On The Cigna Group (CI) Now?
We recently compiled a list of the Billionaire Lee Cooperman’s Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against Lee Cooperman’s other long-term stock picks.
The Cigna Group's Fourth Quarter 2024 Earnings Release Details
Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a conference call the same day.
Cigna (CI) Receives a Buy from Bernstein
In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Cigna (CI – Research Report), with a price target of
STAT7d
Cigna, Centene, Walgreens drop out of J.P. Morgan conference
Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.
Pharm Exec4d
Cigna Expands Access to Fertility and Family-Building Benefits
A new offering in collaboration with Progyny, Inc makes fertility/family-building services more accessible and equitable.
Here's How Much $1000 Invested In Cigna 15 Years Ago Would Be Worth Today
Buying $1000 In CI: If an investor had bought $1000 of CI stock 15 years ago, it would be worth $7,625.07 today based on a price of $278.62 for CI at the time of writing.
Cigna Group stock underperforms Wednesday when compared to competitors
Cigna Group closed $91.51 below its 52-week high ($370.83), which the company achieved on September 16th.
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role (3)
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing in more than $7.
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
Cigna Group stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top
Why The Cigna Group (CI) Is One of the Cheapest Stocks with Biggest Upside Potential?
We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against other cheapest stocks with biggest upside potential.